May 5th: Free Presentation of One-year IVAN and Two-year CATT Study Results

Wednesday, May 02, 2012

ARVO will host a complimentary presentation of the one-year results from the U.K.’s Inhibition of VEGF in Age-related Choroidal Neovascularisation (IVAN) study and the two-year results of the Comparison of Age-related Macular Degeneration Treatments Trials (CATT) trial.  These two multicenter randomized clinical trials, sponsored by the National Institute of Health Research in the United Kingdom and the National Eye Institute, respectively, evaluate the relative efficacy and safety of Lucentis and Avastin in the management of neovascular age-related macular degeneration (AMD).   

Register Now

« All News »

Corporate Membership Program

Help support our mission: to provide a collegial open forum for education, to advance the understanding and treatment of vitreoretinal diseases, and to enhance the ability of our members to provide the highest quality of patient care.

Learn how to join »

Foundation of the American Society
of Retina Specialists

A charitable, non-profit Foundation formed by the American Society of Retina Specialists (ASRS) to promote public awareness, continuing medical education, research, and treatment of retinal diseases.

Learn more about the Foundation »

How do you like the new ASRS website?

We created the new site to provide a comprehensive source of timely, relevant information to retina surgeons worldwide—we hope you're finding it useful. Please share your comments and suggestions to help us continue to improve the site. Your input is very valuable.

Send comments to: feedback@asrs.org